Inventiva Pharma
Created in 2012
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
291 5,951Activities
Technologies
Entity types
Location
50 Rue de Dijon, 21121 Daix, France
Daix
France
Employees
Scale: 51-200
Estimated: 114
SIREN
537530255Engaged corporates
4
1 1Added in Motherbase
4 years ago
biotech Value proposition
A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies.
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.
Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SScOriginal language
A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies.
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology.
Home - Inventiva Pharma
https://inventivapharma.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 17 Oct 2024 | | |
 Euronext Finance, Financial Services | Euronext Finance, Financial Services | Other 17 Dec 2018 17 Oct 2024 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 14 Oct 2024 | | |
 AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Capitalistic Not partnership Not event 31 Jan 2022 | | |